Ira Zoot
Publisher and editor of Ketalux. Based in Chicago, Illinois.
About Ira
Ira Zoot is the independent publisher and editor of Ketalux. Based in Chicago, Illinois, Ira commissions, edits, and reviews every article on the site, and is personally responsible for editorial standards, sourcing, corrections, and reader correspondence.
Why Ketalux exists
Ira genuinely believes that ketamine therapy, when delivered responsibly by qualified clinicians, can meaningfully help people who are living with depression, anxiety, PTSD, and other psychological conditions that have not yielded to conventional care. He has seen and read enough — the clinical trials, the patient accounts, the neuroscience of synaptic plasticity — to be convinced that this is a serious, hopeful line of treatment, not a fad.
He also believes ketamine therapy can be genuinely mind-opening: a rare chance to step outside long-standing mental patterns, see one's own life with fresh perspective, and do the harder work of becoming a more honest, more present, more capable person. Used with good intention and good support, it can help people work through what has been stuck for years — grief, trauma, self-criticism, the quiet weight of just getting by.
And Ira believes the body matters too. For people carrying chronic pain, ketamine's emerging role in pain medicine offers real reason for hope — not a cure-all, but a legitimate tool that has already given relief to people who had almost given up on finding any. Reducing suffering, in the mind and in the body, is worth taking seriously.
That conviction is why Ketalux exists. Ira wanted a calm, sourced place to read about all of this — one that respects both the promise and the responsibility that comes with it.
Editorial approach
Ketalux publishes long-form educational material, not marketing. Every clinical page is grounded in peer-reviewed evidence and reviewed for medical responsibility before publication. Ira's role is to keep the coverage honest: hopeful where the evidence supports hope, cautious where the evidence demands caution, and never promotional. Details of the process are in our editorial standards and content review process.
Disclosures
Ketalux is self-funded by its owner and supported by display advertising. Ira does not sell leads to clinics, accept sponsored posts disguised as editorial, or let advertisers influence coverage. Ira is not a physician and does not provide medical advice; treatment decisions belong between a reader and a qualified clinician.
Contact
Email ira@idigits.com for editorial corrections, source suggestions, clinician outreach, or press inquiries.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.
